This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Thomas Jefferson University. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Devon M Middleton: Innovator in Spinal Cord Disease Evaluation
Introduction
Devon M Middleton is a notable inventor based in Philadelphia, PA, who has made significant contributions to the field of spinal cord disease evaluation. His innovative work focuses on developing advanced diagnostic and therapeutic methods that leverage cutting-edge technology.
Latest Patents
Devon M Middleton holds a patent for a novel, quantitative framework for the diagnostic, prognostic, and therapeutic evaluation of spinal cord diseases. This patent describes a method of generating a quantitative characterization of injury presence and status of spinal cord tissue using an adaptive CNN system. The system is designed for diagnostic assessment, surgical planning, and therapeutic strategy. It includes preprocessing for artifact correction of diffusion-based spinal cord MRI data, training an adaptive CNN system with healthy and abnormal spinal cord images, and generating a three-dimensional predictive axonal damage map for quantitative characterization and visualization.
Career Highlights
Devon M Middleton is affiliated with Thomas Jefferson University, where he applies his expertise in spinal cord research. His work has the potential to transform how spinal cord injuries are diagnosed and treated, ultimately improving patient outcomes.
Collaborations
Devon has collaborated with notable colleagues such as Feroze B Mohamed and Christopher J Conklin, contributing to the advancement of research in spinal cord diseases.
Conclusion
Devon M Middleton's innovative contributions to spinal cord disease evaluation highlight the importance of technology in medical diagnostics and treatment. His work exemplifies the potential for advancements in healthcare through dedicated research and collaboration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
